波士顿科学 2026年季度报告

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June30, 2026 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Commission File No.1-11083 BOSTON SCIENTIFIC CORPORATION(Exact name of registrant as specified in its charter) 508 683-4000(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12months (or for such shorter period that the registrant was required to file such reports),and (2)has been subject to such filing requirements for the past 90days. Yes☑No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule405 of RegulationS-T (§232.405 of this chapter) during the preceding 12months (or for such shorter period that theregistrant was required to submit such files). Yes☑No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and "emerging growth company" in Rule12b-2 of the Exchange Act. Large accelerated filer☑Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). Yes☐No☑ The number of shares outstanding of Common Stock, $0.01 par value per share, as of July30, 2026 was 1,449,229,526. TABLE OF CONTENTS Page No. PART IFINANCIAL INFORMATION4ITEM 1.Consolidated Financial Statements4Consolidated Statements of Operations (Unaudited)4Consolidated Statements of Comprehensive Income (Loss) (Unaudited)5Consolidated Balance Sheets (Unaudited)6Consolidated Statements of Stockholders' Equity (Unaudited)7Consolidated Statements of Cash Flows (Unaudited)8Notes to the Consolidated Financial Statements (Unaudited)10ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations39ITEM 3.Quantitative and Qualitative Disclosures About Market Risk52ITEM 4.Controls and Procedures53PART IIOTHER INFORMATION54ITEM 1.Legal Proceedings54ITEM 1A.Risk Factors54ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds54ITEM 5.Other Information54ITEM 6.Exhibits54SIGNATURE56 Cautionary Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q (this Quarterly Report) contains statements that constitute “forward-looking statements” withinthe meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-lookingstatements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend,” “aim,” "goal,""target," "continue," "hope," "may" and similar words. These forward-looking statements include, among other things, statementsregarding our financial and operating performance; acquisitions; clinical trials; business plans and product performance; new andanticipated product approvals and launches; intellectual property; regulations and accounting pronouncements; legal proceedings; taxmatters and regulations; and macroeconomic and geopolitical conditions. These forward-looking statements are based on our beliefs,assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events orperformance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results couldvary materially from the expectations and projections expressed or implied by our forward-looking statements. The forward-looking statements in this Quarterly Report are based on certain risks and uncertainties, including the risk factorsdescribed in Item 1A under the heading Risk Factors in our most recent Annual Report on Form 10-K and the specific risk factorsdiscussed herein and in connection with forward-looking statements made throughout this Quarterly Report, which could cause actualresults to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risksand uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and maycause actual results to differ materially from those contemplated by the statements expressed in this Quarterly Rep